EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Artificial intelligence and radiomics in glioma: A bibliometric analysis of key trends and future frontiers

Shichao Liu, Risheng Liang

DIGITAL HEALTH · 2026-02 · 12

DOI: 10.1177/20552076251404503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift DIGITAL HEALTH, online erschienen am 10.08.2026. Verfasst von Shichao Liu und 1 weiteren Autor:innen. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Gliomas, the most common primary malignant brain tumors, present diagnostic and therapeutic challenges. Artificial intelligence (AI) and radiomics offer promising solutions, yet a macroscopic overview of this rapidly evolving field is lacking. This study provides a bibliometric analysis of research trends, hotspots, and future frontiers to guide clinical application.

Methods

We retrieved literature from five major databases (WoSCC, PubMed, Embase, Scopus, and Cochrane Library) from 2004 to 2025. Using CiteSpace and RStudio, we analyzed publication trends, keyword co-occurrence, collaboration networks, and citation patterns to visualize the research landscape.

Results

A total of 595 publications were analyzed, revealing an exponential growth trend, with 76.3% of articles published between 2020 and 2024. China (191 articles) and the United States (163 articles) were the leading countries in publication volume. The analysis identified deep learning (DL) and radiogenomics as major research hotspots, with a clear paradigm shift from traditional feature engineering to end-to-end automated models.

Conclusion

This bibliometric analysis highlights the rapid evolution of AI and radiomics in glioma research, marked by a paradigm shift from feature-based methods to DL and multi-omics frameworks. Despite significant progress, critical hurdles to clinical translation remain; for example, adherence to the Image Biomarker Standardisation Initiative (IBSI) guidelines is limited, and large-scale, multi-center validation studies are urgently needed. This study provides a crucial roadmap emphasizing the need for explainable AI and robust validation to bridge the gap between research and clinical practice.

Zitieren

APA

Liu, S., & Liang, R. (2026). Artificial intelligence and radiomics in glioma: A bibliometric analysis of key trends and future frontiers. DIGITAL HEALTH, 12. https://doi.org/10.1177/20552076251404503

Vancouver

Liu S, Liang R. Artificial intelligence and radiomics in glioma: A bibliometric analysis of key trends and future frontiers. DIGITAL HEALTH. 2026;12. doi:10.1177/20552076251404503

BibTeX
@article{Liu2026,
  author = {Liu, Shichao and Liang, Risheng},
  title = {Artificial intelligence and radiomics in glioma: A bibliometric analysis of key trends and future frontiers},
  journal = {DIGITAL HEALTH},
  year = {2026},
  volume = {12},
  doi = {10.1177/20552076251404503}
}
Kostenlos starten →